BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...a new position. He was managing director of Morgan Stanley’s global healthcare group. Diagnostics company Meridian Bioscience Inc....
...will be based in the firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian...
BioCentury | Jul 26, 2019
Finance

Earnings on deck

...7/30 Pre $1.16 $1.06 9% Bayer AG (Xetra:BAYN) 7/30 During (A) NA € 0.87 NA Meridian Bioscience Inc....
BioCentury | Apr 26, 2019
Finance

Earnings on deck

...4/30 Pre $0.40 -$0.01 NA Merck & Co. Inc. (NYSE:MRK) 4/30 Pre $1.05 $1.05 0% Meridian Bioscience Inc....
BioCentury | Nov 2, 2018
Finance

Earnings on deck

...NYSE:AZN) 11/8 Pre $0.73 $1.12 -35% Endo International plc (NASDAQ:ENDP) 11/8 Pre $0.59 $0.91 -35% Meridian Bioscience Inc....
BioCentury | Jul 27, 2018
Finance

Earnings on deck

...Tokyo:4508) (A) 7/30 NA NA ¥30.27 NA Incyte Corp. (NASDAQ:INCY) 7/31 Pre $0.34 -$0.06 NA Meridian Bioscience Inc....
BioCentury | Apr 20, 2018
Finance

Earnings on deck

...NYSE:ABBV) 4/26 Pre $1.80 $1.28 41% Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) 4/26 Pre $1.50 $1.38 9% Meridian Bioscience Inc....
BioCentury | Oct 11, 2017
Company News

Management tracks: Aerpio, Scancell, TCR2

...He was chief business officer and COO at Benitec Biopharma Ltd. (ASX:BLT; NASDAQ:BNTC). Diagnostics company Meridian Bioscience Inc....
BioCentury | Jul 21, 2017
Finance

Earnings on deck

...Pre $1.78 $1.44 24% Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) (B) 7/27 Pre NA $0.11 NA Meridian Bioscience Inc....
BioCentury | Apr 22, 2017
Finance

Earnings on deck

...LSE:AZN; NYSE:AZN) 4/27 Pre $0.82 $0.95 -14% Celgene Corp. (NASDAQ:CELG) 4/27 Pre $1.64 $1.32 24% Meridian Bioscience Inc....
BioCentury | Feb 24, 2017
Company News

TruQuick sales and marketing update

...transmitted, respiratory, gastrointestinal and cardiac diseases and cancer. Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati, Ohio Business: Diagnostic Jaime De Leon Meridian Bioscience Inc. TruQuick...
Items per page:
1 - 10 of 162
BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...a new position. He was managing director of Morgan Stanley’s global healthcare group. Diagnostics company Meridian Bioscience Inc....
...will be based in the firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian...
BioCentury | Jul 26, 2019
Finance

Earnings on deck

...7/30 Pre $1.16 $1.06 9% Bayer AG (Xetra:BAYN) 7/30 During (A) NA € 0.87 NA Meridian Bioscience Inc....
BioCentury | Apr 26, 2019
Finance

Earnings on deck

...4/30 Pre $0.40 -$0.01 NA Merck & Co. Inc. (NYSE:MRK) 4/30 Pre $1.05 $1.05 0% Meridian Bioscience Inc....
BioCentury | Nov 2, 2018
Finance

Earnings on deck

...NYSE:AZN) 11/8 Pre $0.73 $1.12 -35% Endo International plc (NASDAQ:ENDP) 11/8 Pre $0.59 $0.91 -35% Meridian Bioscience Inc....
BioCentury | Jul 27, 2018
Finance

Earnings on deck

...Tokyo:4508) (A) 7/30 NA NA ¥30.27 NA Incyte Corp. (NASDAQ:INCY) 7/31 Pre $0.34 -$0.06 NA Meridian Bioscience Inc....
BioCentury | Apr 20, 2018
Finance

Earnings on deck

...NYSE:ABBV) 4/26 Pre $1.80 $1.28 41% Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) 4/26 Pre $1.50 $1.38 9% Meridian Bioscience Inc....
BioCentury | Oct 11, 2017
Company News

Management tracks: Aerpio, Scancell, TCR2

...He was chief business officer and COO at Benitec Biopharma Ltd. (ASX:BLT; NASDAQ:BNTC). Diagnostics company Meridian Bioscience Inc....
BioCentury | Jul 21, 2017
Finance

Earnings on deck

...Pre $1.78 $1.44 24% Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) (B) 7/27 Pre NA $0.11 NA Meridian Bioscience Inc....
BioCentury | Apr 22, 2017
Finance

Earnings on deck

...LSE:AZN; NYSE:AZN) 4/27 Pre $0.82 $0.95 -14% Celgene Corp. (NASDAQ:CELG) 4/27 Pre $1.64 $1.32 24% Meridian Bioscience Inc....
BioCentury | Feb 24, 2017
Company News

TruQuick sales and marketing update

...transmitted, respiratory, gastrointestinal and cardiac diseases and cancer. Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati, Ohio Business: Diagnostic Jaime De Leon Meridian Bioscience Inc. TruQuick...
Items per page:
1 - 10 of 162